Search results for #upadacitinib
👀Nearly half of patients with #GCA who received #upadacitinib while tapering steroids achieved remission from weeks 12 through 52 in a phase 3 trial Check Healio for more on this news from @abbvie ⬇️ healio.com/news/rheumatol…
Patients with #GiantCellArteritis (GCA) who received #Upadacitinib with a #SteroidTaperRegimen achieved sustained remission, according to results from the phase 3 #SELECTGCA study. Read more: brnw.ch/21wJ4aj #GCA #Optometry #EyeHealth #ClinicalTrial #MedTwitter
Among patients with moderate to severe #atopic #dermatitis, #upadacitinib was found to be superior to #dupilumab for skin clearance and itch resolution, according to results from a head-to-head phase 3b/4 study. buff.ly/4bbNCVM
NEW TODAY: AbbVie announced topline data from its LEVEL-UP study evaluating the safety and efficacy of #upadacitinib 15mg once daily compared to dupilumab in adolescent and adult patients with moderate to severe AD and inadequate responses to systemics. dermatologytimes.com/view/upadaciti…
Can in vitro/in silico tools improve colonic concentration estimations for oral extended-release formulations? A case study with upadacitinib. | Abdul W. Basit @School_Pharmacy | @ProfAWBasit @UKICRS #ColonicTargeting #ExtendedRelease #upadacitinib doi.org/10.1016/j.jcon…
Results of the SELECT-GCA study showed approximately half of patients with giant cell arteritis treated with #upadacitinib plus a steroid tapering regimen were able to achieve sustained remission through week 52. hcplive.com/view/phase-3-u… #RheumTwitter
#upadacitinib achieves clinical and endoscopic outcomes in #crohnsdisease regardless of prior biologic exposures sciencedirect.com/science/articl…
Post-hoc analysis results from U-EXCEL, U-EXCEED & U-ENDURE: #Rinvoq 45 mg (#upadacitinib, @abbvie) prompts ‘rapid resolution’ of #Crohnsdisease symptoms as early as day 5 ⬇️⬇️ healio.com/news/gastroent…
Recent findings from Cope, et al. showed that #upadacitinib reduces progression to #RA in high-risk patients. Head on over to the #IMIDForum now to get all the latest news: imidforum.com/publications/6…
New 5-year data suggest a patient with RA not responding to #adalimumab or #upadacitinib may fare better switching to the other. Read findings from the phase 3 SELECT-COMPARE: hcplive.com/view/switching…
Disfrutemos de este mes que parece que nos queda juntos 😍 Obviamente me da miedo el cambio... incluso no estoy segura de ello... pero no puedo con más infecciones… Mi cuerpo está cansado de pelear...😞 Así que me temo que nuestra relación se termina #Upadacitinib
Pues parece que me va a tocar ir despidiendo al #Upadacitinib 😩 Te probé con más esperanza que miedo... Fui la primera y me ayudaste y eso ha hecho que ayudes a otrxs muchxs pacientes Pero parece que nuestra relación va llegando a su fin... 😣
Calling #IBD patients with experience of taking #upadacitinib. Did the drug affect your skin? If so, how did you treat this?
Learn about how long-term #upadacitinib use affects laboratory parameters by watching the new Discussing Rheumatology podcast, live now on the IMIDForum.com 🚨🎙️ imidforum.com/podcasts/episo…
Upadacitinib Reduces Crohn’s Disease Symptoms Within the First Week of Induction Therapy - Clinical Gastroenterology and Hepatology cghjournal.org/article/S1542-… #upadacitinib #IBD #ulcerativecolitis #crohn
The latest Literature Highlights covering a study on the effect of #upadacitinib on safety outcomes is now available on The IMID forum. These slides are available to view or download for free! Find them here ➡️ imidforum.com/literature-rev…
The latest study by Charles-Schoeman, et al. investigated long-term changes in laboratory parameters in people with #RA that were treated with #upadacitinib. Head to the #IMID Forum today to read about all the latest developments in the world of #RA imidforum.com/publications/6…
Join Iain McInnes on the Discussing Rheumatology podcast on the #IMIDForum. Here, he discusses Caporali et al.’s paper on long-term #baricitinib efficacy, and Charles-Schoeman et al.’s study on long-term #upadacitinib use and laboratory parameters imidforum.com/podcasts/episo…
Anyone with experience of #upadacitinib who can share their experience with @imjustkennedy? Thanks. #IBD #Crohns #CrohnsDisease
Anyone with experience of #upadacitinib who can share their experience with @imjustkennedy? Thanks. #IBD #Crohns #CrohnsDisease
Charles-Schoeman, et al. found a dose-dependent relationship between #upadacitinib and changes in laboratory parameters in people with #RA. View the full free slide deck summary now 📈📈 imidforum.com/publications/6…
Rinvoq @Upadacitinib
12 Followers 0 Following